NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the ...

Over the next 12 years through NHS primary care providers, 1.6 million people are expected to receive tirzepatide, a weight ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...

The promise of stem cell therapy is powerful. Scientists can draw versatile cells from the human body and deliver them to ...

To boost mood and manliness, men are spending lots of money on the hormone testosterone—yet they may see trouble instead of ...

A new approach induces the patient’s body to produce its own CAR-T cells, relying on the same messenger RNA (mRNA) technology ...

I wish I could tell you that after recently turning 50, I plan to be mindful and proactive about age-related health issues.

Currently, new parents are offered a blood spot test for their babies, normally when the child is five days old, to check ...

THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called ‘fat jabs’ will be made ...

Renowned American physician‑scientist Frederick R. Appelbaum, MD, discusses the development of bone marrow transplantation as a curative therapy at the 2025 ACVIM Forum ...